Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
Cantor Fitzgerald
Boehringer Ingelheim
Healthtrust
Federal Trade Commission
Harvard Business School
Daiichi Sankyo
Fuji

Generated: August 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020978

« Back to Dashboard

NDA 020978 describes ZIAGEN, which is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ZIAGEN profile page.

The generic ingredient in ZIAGEN is abacavir sulfate. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the abacavir sulfate profile page.
Summary for 020978
Tradename:ZIAGEN
Applicant:Viiv Hlthcare
Ingredient:abacavir sulfate
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 020978
Suppliers and Packaging for NDA: 020978
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZIAGEN abacavir sulfate SOLUTION;ORAL 020978 NDA ViiV Healthcare Company 49702-222 N 49702-222-48

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrengthEQ 20MG BASE/ML
Approval Date:Dec 17, 1998TE:AARLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 14, 2018Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Aug 4, 2019Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020978

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare ZIAGEN abacavir sulfate SOLUTION;ORAL 020978-001 Dec 17, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Viiv Hlthcare ZIAGEN abacavir sulfate SOLUTION;ORAL 020978-001 Dec 17, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
US Department of Justice
Teva
Medtronic
AstraZeneca
Johnson and Johnson
Chubb
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.